Report cover image

Iron Drugs Market by Product (Ferric Carboxymaltose, Iron Dextran, Iron Sucrose), Application (Cancer, Chronic Kidney Disease, Inflammatory Bowel Disease) - Global Forecast 2024-2030

Publisher 360iResearch
Published Jan 15, 2024
Length 194 Pages
SKU # IRE18445247

Description

Iron Drugs Market by Product (Ferric Carboxymaltose, Iron Dextran, Iron Sucrose), Application (Cancer, Chronic Kidney Disease, Inflammatory Bowel Disease) - Global Forecast 2024-2030


The Iron Drugs Market size was estimated at USD 2.66 billion in 2023 and expected to reach USD 2.84 billion in 2024, at a CAGR 6.55% to reach USD 4.16 billion by 2030.

Global Iron Drugs Market

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Iron Drugs Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Iron Drugs Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Iron Drugs Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Accrufer, Akebia Therapeutics, Inc., Alembic Pharmaceuticals Limited, Alkem Laboratories Ltd., Aqunova Pharma Private Limited, Astraea Life Sciences Pvt Ltd., Bluebird Bio, Inc., Cadila Pharmaceuticals Ltd., Corona Remedies Pvt Ltd., Covis Pharma GmbH, Dr. Reddy's Laboratories, Emcure Pharmaceuticals, Glenmark Pharmaceuticals Ltd., Global Calcium Pvt.Ltd, GSK PLC, Gujarat Terce Laboratories Ltd., Lupin Ltd., Pfizer Inc., Pharmacosmos A/S, Pieris Pharmaceuticals, Inc., Sanofi S.A., Solitaire Pharmacia Pvt. Ltd., Sun Pharmaceutical Industries Limited, and Takeda Pharmaceutical Company Limited.

Market Segmentation & Coverage

This research report categorizes the Iron Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product
Ferric Carboxymaltose

Iron Dextran

Iron Sucrose

Application
Cancer

Chronic Kidney Disease

Inflammatory Bowel Disease

Region
Americas
Argentina

Brazil

Canada

Mexico

United States
California

Florida

Illinois

New York

Ohio

Pennsylvania

Texas

Asia-Pacific
Australia

China

India

Indonesia

Japan

Malaysia

Philippines

Singapore

South Korea

Taiwan

Thailand

Vietnam

Europe, Middle East & Africa
Denmark

Egypt

Finland

France

Germany

Israel

Italy

Netherlands

Nigeria

Norway

Poland

Qatar

Russia

Saudi Arabia

South Africa

Spain

Sweden

Switzerland

Turkey

United Arab Emirates

United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Iron Drugs Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Iron Drugs Market?
3. What are the technology trends and regulatory frameworks in the Iron Drugs Market?
4. What is the market share of the leading vendors in the Iron Drugs Market?
5. Which modes and strategic moves are suitable for entering the Iron Drugs Market?

Note: PDF & Excel + Online Access - 1 Year

Table of Contents

194 Pages
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Iron Drugs Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rise in the prevalence of iron disorders and deficiencies
5.1.1.2. Growing awareness regarding the availability of iron supplements
5.1.1.3. Government initiatives to deliver iron drugs to children and pregnant women
5.1.2. Restraints
5.1.2.1. High cost and incidences of product recall
5.1.3. Opportunities
5.1.3.1. Advancements in manufacturing of iron drugs
5.1.3.2. Significant investment to accelerate iron drug manufacturing
5.1.4. Challenges
5.1.4.1. Adverse effects associated with iron drugs
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Iron Drugs Market, by Product
6.1. Introduction
6.2. Ferric Carboxymaltose
6.3. Iron Dextran
6.4. Iron Sucrose
7. Iron Drugs Market, by Application
7.1. Introduction
7.2. Cancer
7.3. Chronic Kidney Disease
7.4. Inflammatory Bowel Disease
8. Americas Iron Drugs Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Iron Drugs Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.
10. South Korea
9.
11. Taiwan
9.
12. Thailand
9.
13. Vietnam
10. Europe, Middle East & Africa Iron Drugs Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.
10. Nigeria
10.
11. Norway
10.
12. Poland
10.
13. Qatar
10.
14. Russia
10.
15. Saudi Arabia
10.
16. South Africa
10.
17. Spain
10.
18. Sweden
10.
19. Switzerland
10.
20. Turkey
10.
21. United Arab Emirates
10.
22. United Kingdom
11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.2. Market Share Analysis, By Key Player
11.3. Competitive Scenario Analysis, By Key Player
12. Competitive Portfolio
12.1. Key Company Profiles
12.1.1. AbbVie Inc.
12.1.2. Accrufer
12.1.3. Akebia Therapeutics, Inc.
12.1.4. Alembic Pharmaceuticals Limited
12.1.5. Alkem Laboratories Ltd.
12.1.6. Aqunova Pharma Private Limited
12.1.7. Astraea Life Sciences Pvt Ltd.
12.1.8. Bluebird Bio, Inc.
12.1.9. Cadila Pharmaceuticals Ltd.
12.1.
10. Corona Remedies Pvt Ltd.
12.1.
11. Covis Pharma GmbH
12.1.
12. Dr. Reddy's Laboratories
12.1.
13. Emcure Pharmaceuticals
12.1.
14. Glenmark Pharmaceuticals Ltd.
12.1.
15. Global Calcium Pvt.Ltd
12.1.
16. GSK PLC
12.1.
17. Gujarat Terce Laboratories Ltd.
12.1.
18. Lupin Ltd.
12.1.
19. Pfizer Inc.
12.1.
20. Pharmacosmos A/S
12.1.
21. Pieris Pharmaceuticals, Inc.
12.1.
22. Sanofi S.A.
12.1.
23. Solitaire Pharmacia Pvt. Ltd.
12.1.
24. Sun Pharmaceutical Industries Limited
12.1.
25. Takeda Pharmaceutical Company Limited
12.2. Key Product Portfolio
13. Appendix
13.1. Discussion Guide
13.2. License & Pricing
FIGURE 1. IRON DRUGS MARKET RESEARCH PROCESS
FIGURE 2. IRON DRUGS MARKET SIZE, 2023 VS 2030
FIGURE 3. IRON DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. IRON DRUGS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. IRON DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. IRON DRUGS MARKET DYNAMICS
FIGURE 7. IRON DRUGS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. IRON DRUGS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. IRON DRUGS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 10. IRON DRUGS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS IRON DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 12. AMERICAS IRON DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES IRON DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 14. UNITED STATES IRON DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. ASIA-PACIFIC IRON DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. ASIA-PACIFIC IRON DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA IRON DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA IRON DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. IRON DRUGS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 20. IRON DRUGS MARKET SHARE, BY KEY PLAYER, 2023

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us